Sijmen de Vries

Leeftijd : 63

Vermogen : 8 612 855 USD

Belangrijkste bedrijven :

Pharming Group N.V. -

Midatech Pharma plc

Overzicht

Sijmen de Vries is Chief Executive Officer & Executive Director at Pharming Group NV and Chief Executive Officer at Pharming Intellectual Property BV (a subsidiary of Pharming Group NV).

He is also on the board of Sylus Pharmaceuticals Ltd. and Midatech Pharma Plc and Finish Partner at BioConnection BV.

He previously held the position of Chief Executive Officer at Morphochem AG and Chief Executive Officer of 4-Antibody AG.

He received an MBA from Ashridge Business School and a doctorate from the University of Amsterdam.

Posities en verantwoordelijkheden van Sijmen de Vries

Naam	Titel	Van
Pharming Group N.V. (Farmaceutische producten)	Chairman-Management Board, CEO & CFO	2020
Midatech Pharma plc (Biotechnologie & Medisch Onderzoek)	Independent Non-Executive Director	2014
Pharming Intellectual Property BV	Chief Executive Officer	-
Sylus Pharmaceuticals Ltd.	Non-Executive Director	2010
BioConnection BV	Finish Partner	-

Belangnemingen van Sijmen de Vries

Naam	Aandelen	%	Totale waarde
Pharming Group N.V. (PHARM) (Farmaceutische producten)	7 444 143	1,14%	8 612 129 USD
Midatech Pharma plc (MTPH) (Biotechnologie & Medisch Onderzoek)	26 241	0,024%	726 USD

Sijmen de VriesPersoonlijk netwerk

Naam	Verwante bedrijven
Mireille Sanders	Pharming Group N.V.
Robert Friesen	Pharming Group N.V.
Barbara Yanni	Pharming Group N.V.
Deborah A. Jorn	Pharming Group N.V.
Ruud van Outersterp	Pharming Group N.V.
Jabine T. M. van der Meijs	Pharming Group N.V.
Steven Baert	Pharming Group N.V.
Jeroen Henk Wakkerman	Pharming Group N.V.
Paul Jai Sekhri	Pharming Group N.V.
Leonard Kruimer	Pharming Group N.V.